Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Modern Healthcare Technology Holdings (STU:M3L) Cash Conversion Cycle Explanation
Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.
Be Aware
CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.
The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.
Modern Healthcare Technology Holdings Cash Conversion Cycle Related Terms
Modern Healthcare Technology Holdings Cash Conversion Cycle Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Modern Healthcare Technology Holdings Cash Conversion Cycle Chart
STU:M3L vs ROL, SCI, HRB: Cash Conversion Cycle Comparison
For the Personal Services subindustry, Modern Healthcare Technology Holdings's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Modern Healthcare Technology Holdings Cash Conversion Cycle vs Personal Services Industry
For the Personal Services industry and Consumer Cyclical sector, Modern Healthcare Technology Holdings's Cash Conversion Cycle distribution charts can be found below:
* The bar in red indicates where Modern Healthcare Technology Holdings's Cash Conversion Cycle falls into.
Modern Healthcare Technology Holdings Cash Conversion Cycle Calculation
Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.
Cash Conversion Cycle is one of several measures of management effectiveness.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Modern Healthcare Technology Holdings (STU:M3L) has a Cash Conversion Cycle of 38.38 as of Mar. 2026. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Modern Healthcare Technology Holdings and its competitors.
Is Modern Healthcare Technology Holdings' Cash Conversion Cycle too high?
Modern Healthcare Technology Holdings' current Cash Conversion Cycle is 38.38. The Personal Services industry median Cash Conversion Cycle is 20.22. Modern Healthcare Technology Holdings' value of 38.38 is 89.8% above this industry median.
How does Modern Healthcare Technology Holdings' Cash Conversion Cycle compare to ROL and SCI?
Modern Healthcare Technology Holdings' Cash Conversion Cycle of 38.38 can be compared against companies in the Personal Services industry. The industry median Cash Conversion Cycle is 20.22. Modern Healthcare Technology Holdings' value of 38.38 is 89.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for a Personal Services company?
The median Cash Conversion Cycle among Personal Services companies is 20.22, based on 95 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Modern Healthcare Technology Holdings's current Cash Conversion Cycle of 38.38 is 89.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Modern Healthcare Technology Holdings and its competitors. For the Personal Services industry, the median Cash Conversion Cycle is 20.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Modern Healthcare Technology Holdings's current Cash Conversion Cycle is 38.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Modern Healthcare Technology Holdings stock overvalued right now?
Based on GuruFocus' analysis, Modern Healthcare Technology Holdings (STU:M3L) is currently considered Possible Value Trap. The stock's GF Value™ is €0.01, compared to a current price of €0.01 — trading 40% below its estimated fair value. The current Cash Conversion Cycle is 38.38 and 89.8% above the Personal Services industry median of 20.22. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For Modern Healthcare Technology Holdings (STU:M3L), the current Cash Conversion Cycle is 38.38 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Modern Healthcare Technology Holdings Ltd is an investment holding company. The company's operating segment includes Beauty and wellness services and Skincare and wellness products. The company generates maximum revenue from Beauty and wellness services segment. The Beauty and Wellness Services segment of the company is engaged in the provision of beauty and wellness services which provides a wide range of health and beauty services, covering skin care, slimming, massage, spa, hair care, manicure, hair removal, makeup, joint care, and privacy care. Geographically, the company derives the maximum of its revenue from Hong Kong and has a presence in Singapore; China, and Australia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:M3L has been successfully added to your 
